0001800934-20-000002.txt : 20200123
0001800934-20-000002.hdr.sgml : 20200123
20200123142546
ACCESSION NUMBER: 0001800934-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200123
DATE AS OF CHANGE: 20200123
EFFECTIVENESS DATE: 20200123
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revel Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001800934
IRS NUMBER: 842338101
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-358789
FILM NUMBER: 20541533
BUSINESS ADDRESS:
STREET 1: 953 INDIANA STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: 217-766-4292
MAIL ADDRESS:
STREET 1: 953 INDIANA STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
D
1
primary_doc.xml
X0708
D
LIVE
0001800934
Revel Pharmaceuticals Inc.
953 INDIANA STREET
SAN FRANCISCO
CA
CALIFORNIA
94107
217-766-4292
DELAWARE
None
None
Corporation
true
2019
Aaron
Cravens
953 Indiana Street
San Francisco
CA
CALIFORNIA
94107
Executive Officer
Biotechnology
No Revenues
- 06b
false
2019-12-20
false
true
true
false
100000
1600000
533333
1066667
false
2
0
0
158000
Amount represents yearly compensation
false
Revel Pharmaceuticals Inc.
Aaron Cravens
Aaron Cravens
CEO
2020-01-23